A clinical research study at Rosewell Park Cancer Institute (RPCI) will be examining a new novel immunotherapy approach to treating advanced melanoma.
All News
Advertisement
Prostate cancer is the most common solid organ tumor in men. According to the American Cancer Society, in 2013: about 238,590 new cases of prostate cancer will be diagnosed in the United States; about 29,720 men will die of prostate cancer.
Advertisement
Advertisement
Many men are still receiving potentially unnecessary and costly treatments, even after being diagnosed as having prostate cancer with a low risk of dying.
Advertisement
The impacts the Affordable Care Act (ACA) will have on healthcare delivery will reach far beyond the clinical level. For that reason, America's Health Insurance Plans (AHIP), a strategic partner of The American Journal of Managed Care, knows that cultivating collaborative discussions about health law implementation is only common sense.
Advertisement
Advertisement
Trending on AJMC
1
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
2
TrumpRx Launch Brings Savings—and Uncertainty
3
Exploring Identity, Appearance Experiences Among Patients With Alopecia
4
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
5
